Taiwan FDA registration b2bbf342ba56424a330c07921dd5bd60

Firstep Respiratory Syncytial Virus(RSV) Rapid Test (Non-Sterile)

TW: 聯華呼吸道融合細胞病毒檢測試劑(未滅菌)

Taiwan·Risk Class 1·MD·FIRSTEP BIORESEARCH INC.·Registered Jul 12, 2019 – Jul 12, 2024Expired

Registration details

Analysis ID: b2bbf342ba56424a330c07921dd5bd60
License Form: Ministry of Health Medical Device Manufacturing No. 007851

Company information

Manufacturer: FIRSTEP BIORESEARCH INC.
Manufacturer Country: Taiwan, Province of China
Authorized Representative: FIRSTEP BIORESEARCH INC.

Product details

Intended Use: Limited to the first level identification range of the Measures for the Administration of Medical Devices "Respiratory Fusion Cell Virus Serological Reagent (C.3480)".
Product Type (Level 1): C Immunology and microbiology devices
Product Type (Level 2): C3480 Respiratory Fusion Cell Virus Serological Reagent
Import Information: Produced in Taiwan, China

Dates and status

Registration Date: Jul 12, 2019
Expiry Date: Jul 12, 2024

About this record

Access comprehensive regulatory information for Firstep Respiratory Syncytial Virus(RSV) Rapid Test (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number b2bbf342ba56424a330c07921dd5bd60 and manufactured by FIRSTEP BIORESEARCH INC.. The authorized representative in Taiwan is FIRSTEP BIORESEARCH INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.